Bird-Flu a valuable asset for Indonesia?

Indonesia WILL and then it will NOT and then it WILL and then…..

The Indonesians believe that they need to extract as much out of their “asset”- the bird flu that has been ravaging their country- as they can.

So they have been holding back on the tissue samples of the recent victims of the H5N1 virus in their country from the WHO scientists.

They want guarantees that the Indonesians would not be over charged for any vaccine that results from the resaerch conducted on the tissue samples of the Indon victims.

The Indonesians should remember that the entire world had rushed to their aid (without any previous agreements or guarantees) when the recent tsunami had devastated parts of Indonesia. Billions of dollars were sent by people from all over the world to help the victims of the tsunami.

For a country that seems to have been earmarked for repeated disasters by God for some reasons, the Indon people should start by sending positive vibes to the world community.

Here is a very good article by Revere at the Effect Measure, where they have been following this situation closely:

The Indonesian vaccine solution (again)

Category: Bird fluVaccines Posted on: March 28, 2007 7:42 AM, by revere

So the vaccine sharing summit in Jakarta is over and Indonesia says they will begin sharing virus again. The proviso is that they can’t be shared with pharmaceutical companies until a vaccine-sharing agreement is hammered out with WHO and that will take an estimated 3 months. I’ll be surprised if it is done that quickly, but Hope springs Eternal. Meanwhile the scientific community will be able to see the sequences (at least that’s how I read it) and WHO can prepare seed strains but not distribute them. The agreement should also allow determination if any markers of antiviral resistance have appeared and permit developmnet of diagnostic tests.

We don’t know the details of vaccine sharing because they don’t exist yet. The meeting seemed to accomplish the main thing, get Indonesian provision of the isolates unstuck so surveillance functions can resume. But what we know about the proposed strategy for vaccine sharing doesn’t sound very promising to us:

The meeting endorsed WHO’s efforts to link vaccine manufacturers in developed and developing countries to speed the transfer of influenza vaccine manufacturing technology.”We have struck a balance between the need to continue the sharing of influenza viruses for risk assessment and vaccine development,” Heymann said, “and the need to help ensure that developing countries benefit from sharing without compromising global public health security.”

Individual countries will negotiate how vaccine is made available to them.

“WHO is not involved in financial negotiations, either in selling viruses or buying vaccine,” he added. “Countries will negotiate bilaterally with vaccine manufacturers. We will certainly facilitate if countries are asking for support, but it won’t be standard.”

WHO best practices for sharing flu virus were developed for seasonal influenza vaccine, which has a market in developed countries but in only a few developing countries.

“H5N1 vaccines are a different issue,” Heymann said. “We will now modify our best practices to ensure that they are transparent to the developing countries which are providing samples and which have requested to share in the benefits resulting from those viruses.”

The director-general of WHO is committed to working with pharmaceutical companies and donors to develop a possible stockpile of vaccine for developing countries if they need vaccine, he added, but this is at an early stage of feasibility study. (Cheryl Pellerin, US State Dept. Washington File)

The fundamental problem, as we noted before, is that there isn’t enough productive capacity to make enough vaccine, even for the rich countries. Saying to developing countries, “You negotiate with Big Pharma and have them show you how to make vaccine in your country” doesn’t sound like it will work. We need an international effort to establish regional vaccine institutes on a global basis, financed by governments and international donors and outside the market system.

The Indonesians got what they asked for. Like everything else related to bird flu in that country, it probably won’t work.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: